PRTN3 and rheumatoid arthritis: miR-223 expression level is correlated with ACPA concentration, suggesting again specificity regulation of these miRNAs in inflammatory condition, furthermore miR-223 is overexpressed in serum/plasma from RA patients compared with healthy donors [35] and its expression has been described as decreased at three and 12 months after treatment initiation [36].